Cargando…
A Multi-center, Dose-escalation Study of Human type I Pancreatic Elastase (PRT-201) Administered after Arteriovenous Fistula Creation
PURPOSE: To explore the safety and efficacy of PRT-201. METHODS: Randomized, double-blind, placebo-controlled, single-dose escalation study of PRT-201 (0.0033 to 9 mg) applied after arteriovenous fistula (AVF) creation. Participants were followed for one year. The primary outcome measure was safety....
Autores principales: | Peden, Eric K., Leeser, David B., Dixon, Bradley S., El-Khatib, Mahmoud T., Roy-Chaudhury, Prabir, Lawson, Jeffrey H., Menard, Matthew T., Dember, Laura M., Glickman, Marc H., Gustafson, Pamela N., Blair, Andrew T., Magill, Marianne, Franano, F. Nicholas, Burke, Steven K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159815/ https://www.ncbi.nlm.nih.gov/pubmed/23172172 http://dx.doi.org/10.5301/jva.5000125 |
Ejemplares similares
-
Application of Human Type I Pancreatic Elastase (PRT-201) to the venous Anastomosis of Arteriovenous Grafts in Patients with Chronic Kidney Disease
por: Dwivedi, Amit J., et al.
Publicado: (2014) -
Local Adipose-Associated Mediators and Adaptations Following Arteriovenous Fistula Creation
por: Sharma, Gaurav, et al.
Publicado: (2018) -
Surgical creation of upper extremity arteriovenous fistula and grafts: a narrative review
por: Montelongo, Simon, et al.
Publicado: (2022) -
Inhibition of ovine in vitro fertilization by anti-Prt antibody: hypothetical model for Prt/ZP interaction
por: Pimenta, Jorge, et al.
Publicado: (2013) -
Effects of Recombinant Human Type I Pancreatic Elastase on Human Atherosclerotic Arteries
por: Burke, Steven K., et al.
Publicado: (2014)